相似文献
1
RH5 antigenic landscape shapes vaccine and antibody development.
Trends Pharmacol Sci. 2024 Dec;45(12):1092-1094. doi: 10.1016/j.tips.2024.10.008. Epub 2024 Nov 6.
2
RH5: rationally-designed malaria vaccine antigen improving efficacy.
Trends Parasitol. 2024 Oct;40(10):870-872. doi: 10.1016/j.pt.2024.09.001. Epub 2024 Sep 13.
3
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
Lancet Infect Dis. 2024 Oct;24(10):1105-1117. doi: 10.1016/S1473-3099(24)00312-8. Epub 2024 Jun 13.
4
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Cell. 2024 Sep 5;187(18):4964-4980.e21. doi: 10.1016/j.cell.2024.06.015. Epub 2024 Jul 25.
5
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.
Cell. 2024 Sep 5;187(18):4981-4995.e14. doi: 10.1016/j.cell.2024.06.037. Epub 2024 Jul 25.
6
Functional Comparison of Blood-Stage Malaria Vaccine Candidate Antigens.
Front Immunol. 2019 Jun 4;10:1254. doi: 10.3389/fimmu.2019.01254. eCollection 2019.
7
Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
Infect Immun. 2022 Jan 25;90(1):e0037721. doi: 10.1128/IAI.00377-21. Epub 2021 Oct 25.
8
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
Cell Rep Med. 2024 Jul 16;5(7):101654. doi: 10.1016/j.xcrm.2024.101654.
9
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.
Cell Rep Med. 2021 Jun 21;2(7):100326. doi: 10.1016/j.xcrm.2021.100326. eCollection 2021 Jul 20.
10
The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
PLoS Med. 2010 Jan 19;7(1):e1000218. doi: 10.1371/journal.pmed.1000218.
本文引用的文献
1
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.
Cell. 2024 Sep 5;187(18):4981-4995.e14. doi: 10.1016/j.cell.2024.06.037. Epub 2024 Jul 25.
2
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Cell. 2024 Sep 5;187(18):4964-4980.e21. doi: 10.1016/j.cell.2024.06.015. Epub 2024 Jul 25.
3
The PfRCR complex bridges malaria parasite and erythrocyte during invasion.
Nature. 2024 Jan;625(7995):578-584. doi: 10.1038/s41586-023-06856-1. Epub 2023 Dec 20.
4
PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum.
Nat Microbiol. 2022 Dec;7(12):2039-2053. doi: 10.1038/s41564-022-01261-2. Epub 2022 Nov 17.
5
Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion.
Nat Commun. 2022 Oct 6;13(1):5888. doi: 10.1038/s41467-022-33336-3.
6
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Med. 2021 Jun 11;2(6):701-719.e19. doi: 10.1016/j.medj.2021.03.014.
7
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
Cell. 2019 Jun 27;178(1):216-228.e21. doi: 10.1016/j.cell.2019.05.025. Epub 2019 Jun 13.
8
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex.
Nature. 2019 Jan;565(7737):118-121. doi: 10.1038/s41586-018-0779-6. Epub 2018 Dec 12.
9
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies.
Nature. 2014 Nov 20;515(7527):427-30. doi: 10.1038/nature13715. Epub 2014 Aug 17.
10
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum.
Nature. 2011 Nov 9;480(7378):534-7. doi: 10.1038/nature10606.
Zotero 插件